Anti-MDA5 dermatomyositis after COVID-19 vaccination: a case-based review-Reference-Cited by-同舟云学术

Anti-MDA5 dermatomyositis after COVID-19 vaccination: a case-based review

Published:2022-06-04 Issue:9 Volume:42 Page:1629-1641
ISSN:1437-160X
Container-title:Rheumatology International
language:en
Short-container-title:Rheumatol Int

Author:

Gonzalez Daniel^ORCID,Gupta Latika^ORCID,Murthy Vijaya^ORCID,Gonzalez Emilio B.^ORCID,Williamson Katrina A.^ORCID,Makol Ashima^ORCID,Tan Chou Luan^ORCID,Sulaiman Farah Nadiah^ORCID,Shahril Nor Shuhaila^ORCID,Isa Liza Mohd^ORCID,Martín-Nares Eduardo^ORCID,Aggarwal Rohit^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy,Rheumatology

Link

https://link.springer.com/content/pdf/10.1007/s00296-022-05149-6.pdf

Reference60 articles.

1. Rebendenne A et al (2021) SARS-CoV-2 triggers an MDA-5-dependent interferon response which is unable to control replication in lung epithelial cells. J Virol. https://doi.org/10.1128/jvi.02415-20

2. Yin X et al (2021) MDA5 governs the innate immune response to SARS-CoV-2 in lung epithelial cells. Cell Rep 34(2):108628. https://doi.org/10.1016/j.celrep.2020.108628

3. Nombel A, Fabien N, Coutant F (2021) Dermatomyositis with anti-MDA5 antibodies: bioclinical features, pathogenesis and emerging therapies (in eng). Front Immunol 12:773352. https://doi.org/10.3389/fimmu.2021.773352

4. Wang Y, Du G, Zhang G, Matucci-Cerinic M, Furst DE (2020) Similarities and differences between severe COVID-19 pneumonia and anti-MDA-5-positive dermatomyositis-associated rapidly progressive interstitial lung diseases: a challenge for the future, (in eng). Ann Rheum Dis. https://doi.org/10.1136/annrheumdis-2020-218594

5. Wu W et al (2021) Interstitial lung disease in anti-MDA5 positive dermatomyositis (in eng). Clin Rev Allergy Immunol 60(2):293–304. https://doi.org/10.1007/s12016-020-08822-5

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 in patients with interstitial lung disease;COVID-19: An Update;2024-09-01

2. Anti-MDA5 autoantibodies predict clinical dynamics of dermatomyositis following SARS-CoV-2 mRNA vaccination: a retrospective statistical analysis of case reports;Rheumatology International;2024-08-27

3. MDA5-autoimmunity and interstitial pneumonitis contemporaneous with the COVID-19 pandemic (MIP-C);eBioMedicine;2024-06

4. Cutaneous adverse reactions associated with COVID-19 vaccines: Current evidence and potential immune mechanisms;Clinical Immunology;2024-06

5. Characteristics of emerging new autoimmune diseases after COVID‐19 vaccination: A sub‐study by the COVAD group;International Journal of Rheumatic Diseases;2024-05